Long-acting glucagon-like peptide-1 receptor agonist-status December 2018

被引：17

作者：

Holst, Jens Juul ^{[1
,2
]}

机构：

[1] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-220 Copenhagen, Denmark

[2] Univ Copenhagen, Panum Inst, NNF Ctr Basic Metab Res, DK-220 Copenhagen, Denmark

来源：

ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷 / 05期

关键词：

BETA-CELL FUNCTION; GLP-1; RECEPTOR; CARDIOVASCULAR OUTCOMES; HEART-FAILURE; DOUBLE-BLIND; FOOD-INTAKE; TYPE-2; LIRAGLUTIDE; GLUCOSE; SEMAGLUTIDE;

D O I：

10.21037/atm.2019.01.09

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：6

共 31 条

[1] GLP-1 Receptor Expression Within the Human Heart [J].

Baggio, Laurie L. ;

Yusta, Bernardo ;

Mulvihill, Erin E. ;

Cao, Xiemin ;

Streutker, Catherine J. ;

Butany, Jagdish ;

Cappola, Thomas P. ;

Margulies, Kenneth B. ;

Drucker, Daniel J. .

ENDOCRINOLOGY, 2018, 159 (04) :1570-1584

[2] Effects of Exenatide on Measures of β-Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes [J].

Bunck, Mathijs C. ;

Corner, Anja ;

Ellasson, Bjorn ;

Heine, Robert J. ;

Shaginian, Rimma M. ;

Taskinen, Marja-Riitta ;

Smith, Ulf ;

Yki-Jarvinen, Hannele ;

Diamant, Michaela .

DIABETES CARE, 2011, 34 (09) :2041-2047

[3]

Davies MJ, 2018, DIABETES CARE, V41, P2669, DOI [10.2337/dci18-0033, 10.1007/s00125-018-4729-5]

[4] Discovery, characterization, and clinical development of the glucagon-like peptides [J].

Drucker, Daniel J. ;

Habener, Joel F. ;

Holst, Jens Juul .

JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (12) :4217-4227

[5] The Cardiovascular Biology of Glucagon-like Peptide-1 [J].

Drucker, Daniel J. .

CELL METABOLISM, 2016, 24 (01) :15-30

[6] The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action [J].

Hare, Kristine J. ;

Vilsboll, Tina ;

Asmar, Meena ;

Deacon, Carolyn F. ;

Knop, Filip K. ;

Holst, Jens J. .

DIABETES, 2010, 59 (07) :1765-1770

[7] Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial [J].

Hernandez, Adrian F. ;

Green, Jennifer B. ;

Janmohamed, Salim ;

D'Agostino, Ralph B., Sr. ;

Granger, Christopher B. ;

Jones, Nigel P. ;

Leiter, Lawrence A. ;

Rosenberg, Anne E. ;

Sigmon, Kristina N. ;

Somerville, Matthew C. ;

Thorpe, Karl M. ;

McMurray, John J. V. ;

Del Prato, Stefano .

LANCET, 2018, 392 (10157) :1519-1529

[8] Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity [J].

Hjerpsted, Julie B. ;

Flint, Anne ;

Brooks, Ashley ;

Axelsen, Mads B. ;

Kvist, Trine ;

Blundell, John .

DIABETES OBESITY & METABOLISM, 2018, 20 (03) :610-619

[9] Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes [J].

Holman, Rury R. ;

Bethel, M. Angelyn ;

Mentz, Robert J. ;

Thompson, Vivian P. ;

Lokhnygina, Yuliya ;

Buse, John B. ;

Chan, Juliana C. ;

Choi, Jasmine ;

Gustavson, Stephanie M. ;

Iqbal, Nayyar ;

Maggioni, Aldo P. ;

Marso, Steven P. ;

Ohman, Peter ;

Pagidipati, Neha J. ;

Poulter, Neil ;

Ramachandran, Ambady ;

Zinman, Bernard ;

Hernandez, Adrian F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (13) :1228-1239

[10] The physiology of glucagon-like peptide 1 [J].

Holst, Jens Juul .

PHYSIOLOGICAL REVIEWS, 2007, 87 (04) :1409-1439

← 1 2 3 4 →